{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:04:58Z","timestamp":1793729098106,"version":"4.6.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-025-01003-3","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T05:05:14Z","timestamp":1751259914000},"page":"1263-1282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Self-amplifying NRF2\u2013EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer"],"prefix":"10.1038","volume":"6","author":[{"given":"Laura","family":"Antonucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9576-0587","authenticated-orcid":false,"given":"Angeles","family":"Duran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidoro","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0872-6506","authenticated-orcid":false,"given":"Chiara","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-2323","authenticated-orcid":false,"given":"Kosuke","family":"Watari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-4697","authenticated-orcid":false,"given":"Shuvro Prokash","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0800-4658","authenticated-orcid":false,"given":"Yongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhi M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-9968","authenticated-orcid":false,"given":"Luca","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7492-4164","authenticated-orcid":false,"given":"Alexandra","family":"Rundberg Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Todoric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9024","authenticated-orcid":false,"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sanchez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Eibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Vucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Hatzivassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merone","family":"Roose-Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-4225","authenticated-orcid":false,"given":"Dorota","family":"Skowronska-Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-2449","authenticated-orcid":false,"given":"David A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Bar-Sagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-2413","authenticated-orcid":false,"given":"Rosalie C.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-4515","authenticated-orcid":false,"given":"Ludmil B.","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Lorenzo","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4795-8537","authenticated-orcid":false,"given":"Yinling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0147-0998","authenticated-orcid":false,"given":"Maria T.","family":"Diaz-Meco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-3834","authenticated-orcid":false,"given":"Jorge","family":"Moscat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-6473","authenticated-orcid":false,"given":"Michael","family":"Karin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"1003_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"1003_CR2","doi-asserted-by":"publisher","first-page":"688377","DOI":"10.3389\/fonc.2021.688377","volume":"11","author":"DR Principe","year":"2021","unstructured":"Principe, D. R. et al. The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy. Front. Oncol. 11, 688377 (2021).","journal-title":"Front. Oncol."},{"key":"1003_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/apc.2019.06.03","volume":"2","author":"Y Xu","year":"2019","unstructured":"Xu, Y., Liu, J., Nipper, M. & Wang, P. Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma. Ann. Pancreat. Cancer 2, 11 (2019).","journal-title":"Ann. Pancreat. Cancer"},{"key":"1003_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","volume":"22","author":"JL Kopp","year":"2012","unstructured":"Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737\u2013750 (2012).","journal-title":"Cancer Cell"},{"key":"1003_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"1003_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF02784932","volume":"14","author":"T Tabata","year":"1993","unstructured":"Tabata, T., Fujimori, T., Maeda, S., Yamamoto, M. & Saitoh, Y. The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int. J. Pancreatol. 14, 237\u2013244 (1993).","journal-title":"Int. J. Pancreatol."},{"key":"1003_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/gast.1996.v110.pm8536861","volume":"110","author":"M Tada","year":"1996","unstructured":"Tada, M. et al. Analysis of K-RAS gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110, 227\u2013231 (1996).","journal-title":"Gastroenterology"},{"key":"1003_CR8","doi-asserted-by":"publisher","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","volume":"20","author":"AE Becker","year":"2014","unstructured":"Becker, A. E., Hernandez, Y. G., Frucht, H. & Lucas, A. L. Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. World J. Gastroenterol. 20, 11182\u201311198 (2014).","journal-title":"World J. Gastroenterol."},{"key":"1003_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphys.2011.00008","volume":"2","author":"SJ Pandol","year":"2011","unstructured":"Pandol, S. J., Gorelick, F. S. & Lugea, A. Environmental and genetic stressors and the unfolded protein response in exocrine pancreatic function\u2014a hypothesis. Front. Physiol. 2, 8 (2011).","journal-title":"Front. Physiol."},{"key":"1003_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc.2016.66","volume":"16","author":"A Makohon-Moore","year":"2016","unstructured":"Makohon-Moore, A. & Iacobuzio-Donahue, C. A. Pancreatic cancer biology and genetics from an evolutionary perspective. Nat. Rev. Cancer 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1003_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.freeradbiomed.2019.11.034","volume":"147","author":"D Xia","year":"2020","unstructured":"Xia, D. et al. NADPH oxidase 1 mediates caerulein-induced pancreatic fibrosis in chronic pancreatitis. Free Radic. Biol. Med. 147, 139\u2013149 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"1003_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbrc.2009.03.068","volume":"382","author":"C Carriere","year":"2009","unstructured":"Carriere, C., Young, A. L., Gunn, J. R., Longnecker, D. S. & Korc, M. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem. Biophys. Res. Commun. 382, 561\u2013565 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1003_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00595-017-1501-2","volume":"48","author":"J Yamaguchi","year":"2018","unstructured":"Yamaguchi, J., Yokoyama, Y., Kokuryo, T., Ebata, T. & Nagino, M. Cells of origin of pancreatic neoplasms. Surg. Today 48, 9\u201317 (2018).","journal-title":"Surg. Today"},{"key":"1003_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1158\/2159-8290.CD-15-0671","volume":"5","author":"RM Perera","year":"2015","unstructured":"Perera, R. M. & Bardeesy, N. Pancreatic cancer metabolism: breaking it down to build it back up. Cancer Discov. 5, 1247\u20131261 (2015).","journal-title":"Cancer Discov."},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"eabj0486","DOI":"10.1126\/science.abj0486","volume":"373","author":"E Del Poggetto","year":"2021","unstructured":"Del Poggetto, E. et al. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis. Science 373, eabj0486 (2021).","journal-title":"Science"},{"key":"1003_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s43018-020-00134-z","volume":"2","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Nat Cancer 2, 49\u201365 (2021).","journal-title":"Nat Cancer"},{"key":"1003_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature09784","volume":"469","author":"R Margueron","year":"2011","unstructured":"Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343\u2013349 (2011).","journal-title":"Nature"},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nm.4036","volume":"22","author":"KH Kim","year":"2016","unstructured":"Kim, K. H. & Roberts, C. W. Targeting EZH2 in cancer. Nat. Med. 22, 128\u2013134 (2016).","journal-title":"Nat. Med."},{"key":"1003_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cell.2019.10.009","volume":"179","author":"TM Escobar","year":"2019","unstructured":"Escobar, T. M. et al. Active and repressed chromatin domains exhibit distinct nucleosome segregation during DNA replication. Cell 179, 953\u2013963 (2019).","journal-title":"Cell"},{"key":"1003_CR20","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","volume":"22","author":"AP Bracken","year":"2003","unstructured":"Bracken, A. P. et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323\u20135335 (2003).","journal-title":"EMBO J."},{"key":"1003_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1101\/gad.181800.111","volume":"26","author":"J Mallen-St Clair","year":"2012","unstructured":"Mallen-St Clair, J. et al. EZH2 couples pancreatic regeneration to neoplastic progression. Genes Dev. 26, 439\u2013444 (2012).","journal-title":"Genes Dev."},{"key":"1003_CR22","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1053\/j.gastro.2017.01.043","volume":"152","author":"NM Chen","year":"2017","unstructured":"Chen, N. M. et al. Context-dependent epigenetic regulation of nuclear factor of activated T cells 1 in pancreatic plasticity. Gastroenterology 152, 1507\u20131520 (2017).","journal-title":"Gastroenterology"},{"key":"1003_CR23","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1158\/0008-5472.CAN-20-0672","volume":"80","author":"S Patil","year":"2020","unstructured":"Patil, S. et al. EZH2 regulates pancreatic cancer subtype identity and tumor progression via transcriptional repression of GATA6. Cancer Res. 80, 4620\u20134632 (2020).","journal-title":"Cancer Res."},{"key":"1003_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma, Q. Role of NRF2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53, 401\u2013426 (2013).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1003_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","volume":"166","author":"IIC Chio","year":"2016","unstructured":"Chio, I. I. C. et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 166, 963\u2013976 (2016).","journal-title":"Cell"},{"key":"1003_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola, G. M. et al. Oncogene-induced NRF2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106\u2013109 (2011).","journal-title":"Nature"},{"key":"1003_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2049-3002-2-17","volume":"2","author":"LB Sullivan","year":"2014","unstructured":"Sullivan, L. B. & Chandel, N. S. Mitochondrial reactive oxygen species and cancer. Cancer Metab 2, 17 (2014).","journal-title":"Cancer Metab"},{"key":"1003_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ccell.2017.10.011","volume":"32","author":"J Todoric","year":"2017","unstructured":"Todoric, J. et al. Stress-activated NRF2\u2013MDM2 cascade controls neoplastic progression in pancreas. Cancer Cell 32, 824\u2013839 (2017).","journal-title":"Cancer Cell"},{"key":"1003_CR29","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acschembio.6b00651","volume":"11","author":"A Singh","year":"2016","unstructured":"Singh, A. et al. Small molecule inhibitor of NRF2 selectively intervenes therapeutic resistance in KEAP1-deficient NSCLC tumors. ACS Chem. Biol. 11, 3214\u20133225 (2016).","journal-title":"ACS Chem. Biol."},{"key":"1003_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-pharmtox-052220-104025","volume":"62","author":"L Torrente","year":"2022","unstructured":"Torrente, L. & DeNicola, G. M. Targeting NRF2 and its downstream processes: opportunities and challenges. Annu. Rev. Pharmacol. Toxicol. 62, 279\u2013300 (2022).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1003_CR31","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1038\/onc.2011.59","volume":"30","author":"H Akita","year":"2011","unstructured":"Akita, H. et al. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene 30, 3468\u20133476 (2011).","journal-title":"Oncogene"},{"key":"1003_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.redox.2018.07.026","volume":"19","author":"DC Levings","year":"2018","unstructured":"Levings, D. C., Wang, X., Kohlhase, D., Bell, D. A. & Slattery, M. A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations. Redox Biol. 19, 235\u2013249 (2018).","journal-title":"Redox Biol."},{"key":"1003_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nbt.3527","volume":"34","author":"JW Kim","year":"2016","unstructured":"Kim, J. W. et al. Characterizing genomic alterations in cancer by complementary functional associations. Nat. Biotechnol. 34, 539\u2013546 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1003_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2021.02.016","volume":"39","author":"H Su","year":"2021","unstructured":"Su, H. et al. Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis. Cancer Cell 39, 678\u2013693 (2021).","journal-title":"Cancer Cell"},{"key":"1003_CR35","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jhep.2020.01.023","volume":"72","author":"F He","year":"2020","unstructured":"He, F. et al. NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly. J. Hepatol. 72, 1182\u20131195 (2020).","journal-title":"J. Hepatol."},{"key":"1003_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/B978-0-12-405881-1.00009-4","volume":"528","author":"G Covas","year":"2013","unstructured":"Covas, G., Marinho, H. S., Cyrne, L. & Antunes, F. Activation of Nrf2 by H2O2: de novo synthesis versus nuclear translocation. Methods Enzymol. 528, 157\u2013171 (2013).","journal-title":"Methods Enzymol."},{"key":"1003_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7864150","volume":"2016","author":"Z Dong","year":"2016","unstructured":"Dong, Z. et al. Sulforaphane protects pancreatic acinar cell injury by modulating Nrf2-mediated oxidative stress and NLRP3 inflammatory pathway. Oxid. Med. Cell. Longev. 2016, 7864150 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1003_CR38","doi-asserted-by":"publisher","first-page":"aac4383","DOI":"10.1126\/science.aac4383","volume":"350","author":"L Jiao","year":"2015","unstructured":"Jiao, L. & Liu, X. Structural basis of histone H3K27 trimethylation by an active Polycomb repressive complex 2. Science 350, aac4383 (2015).","journal-title":"Science"},{"key":"1003_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11044-9","volume":"10","author":"MT Wang","year":"2019","unstructured":"Wang, M. T. et al. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Nat. Commun. 10, 3055 (2019).","journal-title":"Nat. Commun."},{"key":"1003_CR40","doi-asserted-by":"publisher","first-page":"109635","DOI":"10.1016\/j.biopha.2019.109635","volume":"121","author":"P Jabbarzadeh Kaboli","year":"2020","unstructured":"Jabbarzadeh Kaboli, P. et al. Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer\u2014contradictory effects and future perspectives. Biomed. Pharmacother. 121, 109635 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"1003_CR41","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","volume":"228","author":"B Pedre","year":"2021","unstructured":"Pedre, B., Barayeu, U., Ezerina, D. & Dick, T. P. The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species. Pharmacol. Ther. 228, 107916 (2021).","journal-title":"Pharmacol. Ther."},{"key":"1003_CR42","doi-asserted-by":"publisher","first-page":"8044","DOI":"10.1128\/MCB.25.18.8044-8051.2005","volume":"25","author":"F Katsuoka","year":"2005","unstructured":"Katsuoka, F. et al. Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell. Biol. 25, 8044\u20138051 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"1003_CR43","doi-asserted-by":"publisher","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"DA Scott","year":"2011","unstructured":"Scott, D. A. et al. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 286, 42626\u201342634 (2011).","journal-title":"J. Biol. Chem."},{"key":"1003_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593\u2013602 (1997).","journal-title":"Cell"},{"key":"1003_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"1003_CR46","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.pan.2018.07.009","volume":"18","author":"MLB Peters","year":"2018","unstructured":"Peters, M. L. B. et al. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: results of a simulation model. Pancreatology 18, 928\u2013934 (2018).","journal-title":"Pancreatology"},{"key":"1003_CR47","doi-asserted-by":"publisher","first-page":"e80580","DOI":"10.1371\/journal.pone.0080580","volume":"8","author":"MP Torres","year":"2013","unstructured":"Torres, M. P. et al. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. PLoS ONE 8, e80580 (2013).","journal-title":"PLoS ONE"},{"key":"1003_CR48","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1172\/JCI64498","volume":"123","author":"N Li","year":"2013","unstructured":"Li, N. et al. Loss of acinar cell IKK\u03b1 triggers spontaneous pancreatitis in mice. J. Clin. Invest. 123, 2231\u20132243 (2013).","journal-title":"J. Clin. Invest."},{"key":"1003_CR49","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/nprot.2013.079","volume":"8","author":"M Reichert","year":"2013","unstructured":"Reichert, M. et al. Isolation, culture and genetic manipulation of mouse pancreatic ductal cells. Nat. Protoc. 8, 1354\u20131365 (2013).","journal-title":"Nat. Protoc."},{"key":"1003_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep21127","volume":"6","author":"X Xiao","year":"2016","unstructured":"Xiao, X. et al. PNA lectin for purifying mouse acinar cells from the inflamed pancreas. Sci. Rep. 6, 21127 (2016).","journal-title":"Sci. Rep."},{"key":"1003_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2010.08.013","volume":"7","author":"D Palacios","year":"2010","unstructured":"Palacios, D. et al. TNF\/p38\u03b1\/Polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 7, 455\u2013469 (2010).","journal-title":"Cell Stem Cell"},{"key":"1003_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7161592","volume":"2018","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Isoliquiritigenin ameliorates acute pancreatitis in mice via inhibition of oxidative stress and modulation of the NRF2\/HO-1 pathway. Oxid. Med. Cell. Longev 2018, 7161592 (2018).","journal-title":"Oxid. Med. Cell. Longev"},{"key":"1003_CR53","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/antiox10071107","volume":"10","author":"MA Minati","year":"2021","unstructured":"Minati, M. A., Libert, M., Dahou, H., Jacquemin, P. & Assi, M. N-Acetylcysteine reduces the pro-oxidant and inflammatory responses during pancreatitis and pancreas tumorigenesis. Antioxidants (Basel) 10, 1107 (2021).","journal-title":"Antioxidants (Basel)"},{"key":"1003_CR54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324\u2013338 (2015).","journal-title":"Cell"},{"key":"1003_CR55","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1038\/emboj.2013.204","volume":"32","author":"M Huch","year":"2013","unstructured":"Huch, M. et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5\/R-spondin axis. EMBO J. 32, 2708\u20132721 (2013).","journal-title":"EMBO J."},{"key":"1003_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-62703-287-2_11","volume":"980","author":"W Qiu","year":"2013","unstructured":"Qiu, W. & Su, G. H. Development of orthotopic pancreatic tumor mouse models. Methods Mol. Biol. 980, 215\u2013223 (2013).","journal-title":"Methods Mol. Biol."},{"key":"1003_CR57","doi-asserted-by":"publisher","first-page":"E6166","DOI":"10.1073\/pnas.1519384112","volume":"112","author":"L Antonucci","year":"2015","unstructured":"Antonucci, L. et al. Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. Proc. Natl Acad. Sci. USA 112, E6166\u2013E6174 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1003_CR58","first-page":"505","volume":"54","author":"L Antonucci","year":"2019","unstructured":"Antonucci, L. et al. Mitogen-activated kinase kinase kinase 1 inhibits hedgehog signaling and medulloblastoma growth through GLI1 phosphorylation. Int. J. Oncol. 54, 505\u2013514 (2019).","journal-title":"Int. J. Oncol."},{"key":"1003_CR59","doi-asserted-by":"publisher","unstructured":"Antonucci, L. & Karin, M. Protein extraction, co-immunoprecipitation, and immunoblots. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.eq2lyx3mpgx9\/v1 (2025).","DOI":"10.17504\/protocols.io.eq2lyx3mpgx9\/v1"},{"key":"1003_CR60","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","volume":"52","author":"JS Seidman","year":"2020","unstructured":"Seidman, J. S. et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52, 1057\u20131074 (2020).","journal-title":"Immunity"},{"key":"1003_CR61","doi-asserted-by":"publisher","unstructured":"Antonucci, L., Cobo, I., Nicoletti, C., Molina, A. D. & Karin, M. RNAseq libraries preparation, analysis and data processing. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.j8nlkd486g5r\/v1 (2025).","DOI":"10.17504\/protocols.io.j8nlkd486g5r\/v1"},{"key":"1003_CR62","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"1003_CR63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1003_CR64","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","journal-title":"Science"},{"key":"1003_CR65","doi-asserted-by":"publisher","unstructured":"Antonucci, L., Isidoro, C., Glass, C. K. & Karin, M. ChIPseq libraries preparation. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.x54v97j21g3e\/v1 (2025).","DOI":"10.17504\/protocols.io.x54v97j21g3e\/v1"},{"key":"1003_CR66","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"1003_CR67","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1093\/nar\/gkr533","volume":"39","author":"E Gadaleta","year":"2011","unstructured":"Gadaleta, E. et al. A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws. Nucleic Acids Res. 39, 7900\u20137907 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1003_CR68","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41586-019-1831-x","volume":"576","author":"C Ramirez","year":"2019","unstructured":"Ramirez, C., Hauser, A. D., Vucic, E. A. & Bar-Sagi, D. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis. Nature 576, 477\u2013481 (2019).","journal-title":"Nature"},{"key":"1003_CR69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"1003_CR70","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"1003_CR71","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. Babraham Institute https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2010)."},{"key":"1003_CR72","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"1003_CR73","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"1003_CR74","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"1003_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-1029-6","volume":"17","author":"Y Fan","year":"2016","unstructured":"Fan, Y. et al. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data. Genome Biol. 17, 1\u201311 (2016).","journal-title":"Genome Biol."},{"key":"1003_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 1\u201314 (2016).","journal-title":"Genome Biol."},{"key":"1003_CR77","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156\u20132158 (2011).","journal-title":"Bioinformatics"},{"key":"1003_CR78","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"1003_CR79","unstructured":"The R Core Team. R: A language and environment for statistical computing. CRAN http:\/\/www.r-project.org\/ (2013)."},{"key":"1003_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-6041-2","volume":"20","author":"EN Bergstrom","year":"2019","unstructured":"Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genomics 20, 1\u201312 (2019).","journal-title":"BMC Genomics"},{"key":"1003_CR81","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.xgen.2022.100179","volume":"2","author":"SMA Islam","year":"2022","unstructured":"Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2, 100179 (2022).","journal-title":"Cell Genom."},{"key":"1003_CR82","doi-asserted-by":"publisher","unstructured":"Antonucci, L., Tsuda, M., Shah, V. M., Sears, R. & Karin, M. Histopathology and immunohistochemistry. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.kxygx7pydl8j\/v1 (2025).","DOI":"10.17504\/protocols.io.kxygx7pydl8j\/v1"},{"key":"1003_CR83","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1200\/JCO.2009.24.5639","volume":"28","author":"A Manuyakorn","year":"2010","unstructured":"Manuyakorn, A. et al. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J. Clin. Oncol. 28, 1358\u20131365 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1003_CR84","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ccell.2018.05.003","volume":"33","author":"D Dhar","year":"2018","unstructured":"Dhar, D. et al. Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling. Cancer Cell 33, 1061\u20131077 (2018).","journal-title":"Cancer Cell"},{"key":"1003_CR85","doi-asserted-by":"publisher","unstructured":"Antonucci, L., Scott, D. A. & Karin, M. FAMES analysis. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.5jyl8e5b7l2w\/v1 (2025).","DOI":"10.17504\/protocols.io.5jyl8e5b7l2w\/v1"},{"key":"1003_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"1003_CR87","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","volume":"610","author":"H Su","year":"2022","unstructured":"Su, H. et al. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature 610, 366\u2013372 (2022).","journal-title":"Nature"},{"key":"1003_CR88","doi-asserted-by":"publisher","unstructured":"Ma, J. Y. et al. Deciphering the functional roles of individual cancer alleles across comprehensive cancer genomic studies. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.11.14.567106 (2023).","DOI":"10.1101\/2023.11.14.567106"}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01003-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:34:40Z","timestamp":1757201680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":88,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-01003-3","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.H. and M.G. are employees of Genentech\/Roche and hold company shares. M. Karin is a founder and scientific advisory board member of Elgia Therapeutics and has received research support from Merck, Jenssen and Gossamer Bio. L.B.A is a compensated consultant and has equity interest in io9 and Genome Insight and his spouse is an employee of Biotheranostics. L.B.A. is also an inventor of US patent 10,776,718 for source identification by non-negative matrix factorization. L.B.A. declares US provisional applications 63\/289,601, 63\/269,033, 63\/483,237, 63\/366,392 and 63\/367,846. L.B.A. and S.P.N. also declare US provisional applications 63\/412,835 and 63\/492,348. R.C.S. is a consultant for Larkspur Biosciences and member of the scientific advisory board of RAPPTA Therapeutics and has received sponsored research support from Cardiff Oncology, AstraZeneca Partner of Choice grant award. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}